Employees: 02 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2013-01-15 (13 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MORILLON (74440), Haute-Savoie
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SARL PHARMACIE DE MORILLON : revenue, balance sheet and financial ratios
SARL PHARMACIE DE MORILLON is a French company
founded 13 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MORILLON (74440),
this company of category PME
shows in 2025 a net income positive of 81 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SARL PHARMACIE DE MORILLON (SIREN 790536015)
Indicator
2025
2024
2023
2019
2017
Revenue
N/C
N/C
N/C
N/C
N/C
Net income
80 563 €
41 522 €
34 052 €
48 059 €
70 270 €
EBITDA
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, SARL PHARMACIE DE MORILLON generates positive net income of 81 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 70 k€ -> 81 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
80 563 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 18%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 69%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
17.596%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
68.715%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SARL PHARMACIE DE MORILLON
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2019
2023
2024
2025
Debt ratio
234.749
139.806
50.936
38.935
17.596
Financial autonomy
27.639
36.977
59.164
61.227
68.715
Repayment capacity
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
17.62025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good-14 pts over 3 years
In 2025, the debt ratio of SARL PHARMACIE DE MORILLON (17.60) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
68.72%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good+7 pts over 3 years
In 2025, the financial autonomy of SARL PHARMACIE DE MORILLON (68.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 117.30. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
117.297
Liquidity indicators evolution SARL PHARMACIE DE MORILLON
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2019
2023
2024
2025
Liquidity ratio
114.269
67.431
162.429
119.007
117.297
Interest coverage
None
None
None
None
None
Sector positioning
Liquidity ratio
117.32025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Watch-15 pts over 3 years
In 2025, the liquidity ratio of SARL PHARMACIE DE MORILLON (117.30) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of SARL PHARMACIE DE MORILLON in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SARL PHARMACIE DE MORILLON is estimated at
1 279 752 €
(range 868 446€ - 2 008 108€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
868k€1279k€2008k€
1 279 752 €Range: 868 446€ - 2 008 108€
NAF 5 année 2025
Valuation method used
Net Income Multiple
80 563 €
×
15.9x
=1 279 753 €
Range: 868 446€ - 2 008 108€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SARL PHARMACIE DE MORILLON with other companies in the same sector:
Frequently asked questions about SARL PHARMACIE DE MORILLON
What is the revenue of SARL PHARMACIE DE MORILLON ?
The revenue of SARL PHARMACIE DE MORILLON is not publicly disclosed (confidential accounts filed with INPI).
Is SARL PHARMACIE DE MORILLON profitable?
Yes, SARL PHARMACIE DE MORILLON generated a net profit of 81 k€ in 2025.
Where is the headquarters of SARL PHARMACIE DE MORILLON ?
The headquarters of SARL PHARMACIE DE MORILLON is located in MORILLON (74440), in the department Haute-Savoie.
Where to find the tax return of SARL PHARMACIE DE MORILLON ?
The tax return of SARL PHARMACIE DE MORILLON is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SARL PHARMACIE DE MORILLON operate?
SARL PHARMACIE DE MORILLON operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart